 |
|
CLINICIAN'S CORNER
New Evidence for Stroke Prevention
Clinical Applications
Sharon E. Straus, MD;
Sumit R. Majumdar, MD;
Finlay A. McAlister, MD
JAMA. 2002;288:1396-1398.
Stroke is a leading cause of morbidity and mortality in most developed nations. There is a significant body of evidence supporting strategies that target primary and secondary stroke prevention. This evidence cannot be broadly applied to all patients, and each patient's situation and values must be considered with regard to shared evidence-based decision making. Several models can be used to apply evidence to individual patients, including formal clinical decision analysis, decision aids, or simpler tools such as the likelihood of being helped vs harmed. Various programmatic models of providing patient care in stroke prevention may also be useful; these include specialized clinics or disease-management programs, anticoagulation management services, and self-testing and management of anticoagulation by patients.
Author Affiliations: Division of General Internal Medicine, University Health Network, University of Toronto, Toronto, Ontario (Dr Straus); and Division of General Internal Medicine, University of Alberta, Edmonton (Drs Majumdar and McAlister).
RELATED ARTICLE
New Evidence for Stroke Prevention: Scientific Review
Sharon E. Straus, Sumit R. Majumdar, and Finlay A. McAlister
JAMA. 2002;288(11):1388-1395.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Expanding Indications for Statins in Cerebral Ischemia: A Quantitative Study
Ovbiagele et al.
Arch Neurol 2005;62:67-72.
ABSTRACT
| FULL TEXT
Hospitalization, Restricted Activity, and the Development of Disability Among Older Persons
Gill et al.
JAMA 2004;292:2115-2124.
ABSTRACT
| FULL TEXT
The specificity of prescription patterns in secondary stroke prevention * Authors' reply
Bellelli et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:512-512.
FULL TEXT
|
